SiRNA Therapeutics: Future Promise for Neurodegenerative Diseases.
Ontology highlight
ABSTRACT: Neurodegenerative diseases (ND), as a group of central nervous system (CNS) disorders, are among the most prominent medical problems of the 21st century. They are often associated with considerable disability, motor dysfunction and dementia and are more common in the aged population. ND imposes a psychologic, economic and social burden on the patients and their families. Currently, there is no effective treatment for ND. Since many ND result from the gain of function of a mutant allele, small interference RNA (siRNA) can be a potential therapeutic agent for ND management. Based on the RNA interference (RNAi) approach, siRNA is a powerful tool for modulating gene expression through gene silencing. However, there are some obstacles in the clinical application of siRNA, including unfavorable
SUBMITTER: Amiri A
PROVIDER: S-EPMC9185778 | biostudies-literature | 2021
REPOSITORIES: biostudies-literature
ACCESS DATA